Central Pacific Bank Trust Division Buys 650 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Central Pacific Bank Trust Division grew its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 6.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 10,079 shares of the company’s stock after acquiring an additional 650 shares during the quarter. Central Pacific Bank Trust Division’s holdings in Option Care Health were worth $234,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of OPCH. Wellington Management Group LLP grew its stake in Option Care Health by 15.5% during the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock worth $310,650,000 after buying an additional 1,328,326 shares in the last quarter. FMR LLC increased its stake in Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after acquiring an additional 4,304,896 shares during the last quarter. Westfield Capital Management Co. LP lifted its stake in Option Care Health by 10.2% during the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after purchasing an additional 599,589 shares during the last quarter. State Street Corp boosted its holdings in shares of Option Care Health by 1.4% in the 3rd quarter. State Street Corp now owns 6,257,172 shares of the company’s stock valued at $195,849,000 after purchasing an additional 83,395 shares in the last quarter. Finally, Thrivent Financial for Lutherans increased its stake in shares of Option Care Health by 7.4% in the 3rd quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock valued at $183,541,000 after purchasing an additional 404,811 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $23.57 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $34.63. The firm has a market cap of $4.01 billion, a PE ratio of 19.81, a price-to-earnings-growth ratio of 2.43 and a beta of 1.33. The firm’s fifty day moving average is $23.32 and its 200-day moving average is $27.84.

Insider Buying and Selling

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of Option Care Health stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the acquisition, the director now directly owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. 0.64% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on OPCH. Barrington Research decreased their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. UBS Group began coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price on the stock. JMP Securities upped their price target on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a report on Monday, September 30th. Finally, Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the company from $38.00 to $26.00 in a report on Thursday, October 31st. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $30.14.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.